G9A expression was also associated with metastasis, where analysis of data on distant metastasis free survival (DMFS, Fig 1C) indicated that metastases were more likely to occur for breast cancer patients with high G9A expression. The gene discussed is EHMT2; the disease is breast carcinoma.